Mucocutaneous Manifestations in HIV/AIDS Patients
Downloads
Background: The main target of human immunodeficiency virus (HIV) is cluster of differentiation 4 (CD4) T lymphocytes and several other immune cells that have CD4 receptors. They are also present in skin and mucosa, such as Langerhans cells (LC). Mucocutaneous lesions are one of the first clinical presentations of immunosuppression in HIV seropositive patients that manifest at different stages of the infection and require early diagnosis and prompt treatment. Purpose: To determine the clinical characteristics and the pattern of various mucocutaneous manifestations in Human immunodeficiency virus/Acquired immune deficiency syndrome (HIV/AIDS) patients at Intermediate Care and Infectious Diseases Dr. Soetomo General Academic Hospital Surabaya. Methods: This is a descriptive retrospective study with a cross-sectional design. The study subject was classified as all HIV-AIDS patients with mucocutaneous manifestations treated in Intermediate Care and Infectious Diseases Dr. Soetomo General Academic Hospital Surabaya in 2019. Result: Out of the 614 patients who participated in the study, 72.1% were males. The majority of patients were in the age group 25–49 years (75.4%). The most common risk factor was heterosexuality (41.7%). Based on the distribution of mucocutaneous manifestations, the most common mucocutaneous manifestation was candidiasis mucocutan 387 patients (49.4%) followed by the pruritic papular eruption (PPE) 118 patients (15.1%) and human papillomavirus infection 57 patients (7.3%). Conclusion: Mucocutaneous manifestations occur throughout the course of HIV infection, and they can be considered as good clinical indicators for the progression of the disease and underlying immune status in resource-poor settings.
Lipworth AD, Freeman E, Saavedra AP. Cutaneous Manifestations of HIV and Human T-Lymphotropic Virus. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al., editors. Fitzpatrick's Dermatology. 9th ed. New York: McGraw-Hill Education; 2019. p. 3107-34.
Murtiastutik D. AIDS. Dalam: Barakbah J, Lumintang H, Martodihardjo S, editor. Buku ajar infeksi menular seksual. Surabaya: Airlangga University Press; 2018.
Haryati MR, Asmarawati TP, Hadi U. Informasi dasar HIV/AIDS. Dalam: Hidayati AN, Rosyid AN, Nugroho CW, Asmarawati TP, Ardhiansyah AO, Bakhtiar A et al., editor. Manajemen HIV/AIDS: terkini, komprehensif, dan multidisiplin. Surabaya: Airlangga University Press; 2019.
Kementerian Kesehatan Republik Indonesia. Infodatin HIV AIDS. Jakarta: Pusat Data dan Informasi Kementerian Kesehatan RI; 2020.
Azfar NA, Khan AR, Zia MA, Humayun A, Malik LM, Jahangir M. Frequency of mucocutaneous manifestations in HIV positive Pakistani patients. J Pak Assoc Dermatol 2011; 21(3): 149-153.
Botting RA, Rana H, Bertram KM, Rhodes JW, Baharlou H, Nasr N, et al. Langerhans cells and sexual transmission of HIV and HSV. Rev Med Virol 2016; 27(2): 1923.
Moustaide K, Nassiri A, BayBay H, Gallouj S, Rabhi S, Mernissi FZ. Profile of dermatological manifestations in seropositive patients correlated with CD4 count sample of a Moroccan population. Yumed Text 2019. 1(1): 1-6.
Sharma P, Agrawal M, Saxena A. A study of sexually transmitted infections among HIV – infected patients in correlation with their CD4 T cell counts. Indian J Clin Exp Dermatology 2020; 6(3): 257–60.
Khat N, Kudligi C, Rathod RM, Kuntoji V. Original article: a clinical study of mucocutaneous manifestation of HIV / AIDs and its correlation with CD4 count. J Pak Assoc Dermatol 2020; 30(4): 550–7.
Pudjiati SR, Dewi NA, Palupi SSA. Correlation between CD4 cell counts with mucocutaneous manifestations: study of HIV patients in Dr. Sardjito General Hospital, Yogyakarta. J thee Med Sci 2018; 50(1): 42–9.
Tahir K, Alam F, Hussain I, Ashraf S. Frequency of mucocutaneous manifestations in HIV positive patients. J Pak Assoc Dermatol 2018; 28(4): 420–5.
Khondker L. Dermatological manifestations of HIV/AIDS patients. J Enam Med Coll 2018; 9(3): 185–8.
Muthanna A, Jamil A. Cutaneous infections among human immunodeficiency virus (HIV) - infected patients in a single centre in Kuala Lumpur, Malaysia. Microbes Infect 2021; 1(1): 1-7.
Haridas N, Muhammed K, Sarita S. Mucocutaneous infections in HIV positive patients attending a tertiary care institution: a descriptive study. Int. J. Dermatol 2017; 1(4): 1-5
Rajput PS, Das AK, Paudel U, Parajuli S. Mucocutaneous disorders in HIV/AIDS at a tertiary care hospital in Nepal: An observational study. Our Dermatol Online 2021; 12(2): 101-105.
Abhinandan HB, Suresh KJ, Asha N, Ramesh K, Manali J, Jitendra B et al. Cutaneous manifestations of HIV-infection in relation with CD4 cell counts in Hadoti region. J Evol Med Dent Sci 2013; 2(36): 6703-14.
Hidayati AN. Infeksi menular seksual pada HIV/AIDS: sifilis, herpes simpleks genitalis, dan kondiloma akuminata. Dalam: Hidayati AN, Rosyid AN, Nugroho CW, Asmarawati TP, Ardhiansyah AO,Bakhtiar A et al., editor. Manajemen HIV/AIDS: Terkini, Komprehensif, dan Multidisiplin. Surabaya: Airlangga University Press; 2019.
Lii YY, Yang SH, Wang RR, Tang JT, Wang HM, Kuang, YQ. Effects of CD4 cell count and antiretroviral therapy on mucocutaneous manifestations among HIV/AIDS patients in Yunnan, China. Int J Dermatol 2019; 1(1): 1-6.
Alinda MD. Dermatosis noninfeksi pada HIV/AIDS. Dalam: Hidayati AN, Rosyid AN, Nugroho CW, Asmarawati TP, Ardhiansyah AO, Bakhtiar A et al., editor. Manajemen HIV/AIDS: Terkini, Komprehensif, dan Multidisiplin. Surabaya: Airlangga University Press; 2019.
Hidayati AN, Sari M. Keganasan oportunis kulit pada HIV/AIDS. Dalam: Hidayati AN, Rosyid AN, Nugroho CW, Asmarawati TP, Ardhiansyah AO, Bakhtiar A et al., editor. Manajemen HIV/AIDS: Terkini, Komprehensif, dan Multidisiplin. Surabaya: Airlangga University Press; 2019.
Copyright (c) 2021 Berkala Ilmu Kesehatan Kulit dan Kelamin
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
